UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Pharma Industry News FDA approves Eisai and Merck’s Lenvima for first-line treatment of liver cancer In a significant development for cancer treatment, Eisai and Merck have announced that the U.S. Food and Drug… bypharmanewsdailyAugust 18, 2018
